Radar · Life Sciences in Barcelona
Best Life Sciences Companies in Barcelona, Spain
The 178 best Life Sciences companies in Barcelona, Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: INBRAIN Neuroelectronics.
By Rohit KhannaTrends & Stories
178companies tracked
$819.1Mdisclosed funding
0unicorns
92have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × BARCELONA
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
576companies analysed
70%cloud-native stacks
2025funding peak (by rounds)
13unicorns
2016median founding year
265kcombined LinkedIn audience
28%of audience held by top 3
5companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Barcelona
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | INBRAIN Neuroelectronics Developer of implantable neurotechnology for decoding and modulating brain activity | $83M | 13 mo ago | Series B | 52 | 2019 | WordPressPleskMySQL+17 | 43 patents Implantable flexible brain electrodes and neurostimulation delivery systems | 1 partnership |
| 2 | Biorce Provider of a clinical assistant platform for drug development | $62M | 4 mo ago | Series A | — | 2024 | Framer SitesApple iCloud MailGoogle Workspace+19 | — | 1 launch |
| 3 | Splice Bio Provider of a proprietary platform for gene therapy 37Funding top 29%Growth top 45%Moat top 48%Tech bottom 49% All 7 signals ▾Fundingtop 29% Growthtop 45% Moattop 48% Techbottom 49% Talentbottom 49% Globalbottom 38% Marketbottom 33% Funding: Raised $56.7M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $57M | 12 mo ago | Series B | 24 | 2020 | WordPressMySQLPHP+22 | — | — |
| 4 | STAT Diagnostica Provider of a diagnostic platform for molecular diagnostics and immunoassays | $54M | 116 mo ago | Series C | — | 2010 | — | 113 patents Microfluidic cartridges for nucleic acid purification and on‑chip biochemical assay processing | — |
| 5 | Anaconda Biomed Developer of medical devices for mechanical thromboectomy procedures | $39M | 78 mo ago | Series B | 28 | 2015 | WordPressApple iCloud MailGoogle Workspace+15 | 101 patents Intravascular thrombectomy and expandable catheter devices for clot extraction | — |
| 6 | Ona Therapeutics Provider of therapeutics solution for metastatic cancer | $35M | 8 mo ago | Series A | 25 | 2019 | WordPressBugHerdMySQL+19 | 30 patents FGFR4 and CD36 targeted therapeutics for cancer treatment | — |
| 7 | DeepUll Developer of diagnostic technology for rapid identification of sepsis-causing pathogens | $35M | 13 mo ago | Series C | 26 | 2020 | PHPNginxCloudflare+11 | — | — |
| 8 | STAT-Dx Point of care system for syndromic testing of respiratory & gastrointestinal pathogens | $34M | 120 mo ago | Acquired | 30 | 2010 | — | — | — |
| 9 | SOM Biotech Developer of platform for screening compounds to treat rare diseases | $29M | 30 mo ago | Series B | 15 | 2009 | — | 117 patents Pharmaceutical compounds and formulations for treating dystrophinopathies, movement disorders, and PKU | — |
| 10 | Seqera Labs Provider of a bioinformatics platform for scientific data analysis and workflow management | $27M | 43 mo ago | Series A | 39 | 2018 | SanitySentryApple iCloud Mail+29 | — | 1 launch · 1 partnership |
| 11 | ORYZON Developer of treatments solutions for cancer and neurodegenerative diseases using epigenetic technology… | $25M | 13 mo ago | Public | 43 | 2000 | DrupalApple iCloud MailMicrosoft 365+10 | — | — |
| 12 | Peptomyc Cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment | $23M | 2 mo ago | Series C | 18 | 2014 | WordPressMySQLPHP+16 | 60 patents Patents concentrated in health & consumer products | — |
| 13 | Aortyx Developer of smart devices for aortic diseases | $21M | 12 mo ago | Series A | 19 | 2018 | — | 3 patents Navigable intravascular catheters for precise minimally invasive procedures | — |
| 14 | Genmedica Small molecule therapeutics for diabetes | $21M | 143 mo ago | Deadpooled | 11 | 2004 | — | — | — |
| 15 | ABAC Therapeutics Early stage biopharma developing precision drugs for MDR bacterial infections | $20M | 41 mo ago | Acquired | 8 | 2014 | — | 31 patents Novel small‑molecule antibiotics for Gram‑positive bacterial infections | — |
| 16 | Neuroelectrics Provider of wireless EEG monitoring and brain stimulation devices | $18M | 65 mo ago | Series A | 62 | 2011 | Wix eCommerceCart FunctionalityWix+17 | — | 1 partnership |
| 17 | AbilityPharma Developer of drugs for the treatment of cancer diseases | $15M | 27 mo ago | Series B | 19 | 2009 | Google MapsApache HTTP Serverlit-html+7 | — | — |
| 18 | Nuage Therapeutics Developer of drugs designed for intrinsically disordered targets | $13M | 35 mo ago | Seed | 15 | 2021 | WordPressMySQLPHP+21 | — | — |
| 19 | ADmit Therapeutics Provider of diagnostic services for early detection of Alzheimer's disease | $13M | 32 mo ago | Series A | 10 | 2017 | — | 18 patents Diagnostic biomarkers for Lewy body dementia and Alzheimer’s disease risk assessment | — |
| 20 | Aelix Therapeutics Developer of therapies for treating HIV | $13M | 77 mo ago | Series A | 10 | 2015 | — | 25 patents TLR7 agonist adjuvant formulations enhancing HIV vaccine immunogenicity | — |
| 21 | Sequentia biotech Bioinformatics technologies and sevices | $11M | 20 mo ago | Series A | 23 | 2013 | WordPressPleskMySQL+24 | — | — |
| 22 | Pharmacelera Hardware and software solutions for computer-aided drug design | $10M | 4 mo ago | Series A | 24 | 2015 | WordPressZohoMySQL+22 | 4 patents AI-driven molecular design and similarity analysis for drug discovery | 1 partnership |
| 23 | NEOS Surgery S.L. Implants for cranial and spinal neurosurgery | $9M | 41 mo ago | Series A | 20 | 2003 | WordPressMySQLPHP+11 | 105 patents Sternal fixation systems and vertebral anchor/chisel tools for spinal and chest surgery | — |
| 24 | Accure Therapeutics Developer of therapeutics to treat CNS diseases | $8M | 72 mo ago | Series A | 12 | 2020 | — | 41 patents Small-molecule gelatinase (MMP) inhibitors for treating neurological disorders | — |
| 25 | Mimark Developer of diagnostic solutions for treating patients with gynecological problems | $7M | 30 mo ago | Seed | 2 | 2021 | WordPressMySQLPHP+15 | — | — |
| 26 | AB-Biotics Developer of probiotic drugs for dental disorders | $7M | 97 mo ago | Acquired | 34 | 2004 | WordPressPleskMySQL+24 | 145 patents Therapeutic probiotic formulations targeting gut, vaginal, oral, and respiratory health | — |
| 27 | Onechain Immunotherapeutics Developer of immunotherapies against hematological malignancies | $7M | 27 mo ago | Seed | 10 | 2020 | RubyTrixYouTube+7 | 28 patents Targeted antibody-based immunotherapies and engineered Vδ1 T-cell therapies for cancer | 1 internship |
| 28 | Devicare Developer of home solutions for diagnosis, prognosis, treatment and monitoring of chronic diseases | $7M | 65 mo ago | Series A | 23 | 2012 | Cart FunctionalityPrestaShopMySQL+25 | 9 patents Treating urinary device complications and providing disposable electrochemical test strips. | — |
| 29 | Oxolife Developer of a first-in-class oral drug improving embryo implantation | $7M | 3 mo ago | Series A | 10 | 2013 | WordPress Block EditorWordPressMySQL+18 | 80 patents Tungsten(VI) salt hydrates for fertility therapeutics and their manufacturing processes | — |
| 30 | Integra Therapeutics Developer of next generation of gene editing tools to cure diseases | $7M | 9 mo ago | Seed | 9 | 2021 | WordPressMySQLPHP+18 | 10 patents Transposase-mediated gene delivery systems for enhanced transgene expression and nuclear localization | — |
| 31 | Orikine Bio Developer of therapeutics for the treatment of immune-mediated diseases | $6M | 18 mo ago | Seed | — | 2022 | — | — | — |
| 32 | Inbiomotion Developer of biomarkers to predict bone metastasis in cancer patients | $5M | 64 mo ago | Series A | 10 | 2010 | — | 80 patents Personalized cancer diagnostics and therapies targeting c-MAF biomarkers in breast and prostate tumors | 1 partnership |
| 33 | Connecta Therapeutics Developer of drugs for treating neurological disorders | $5M | 28 mo ago | Seed | 4 | 2018 | — | — | 1 partnership |
| 34 | Gyala Therapeutics Developer of cell therapies for the treatment of hematological malignancies | $4M | 4 mo ago | Early Stage | 5 | 2020 | — | 9 patents CD84-targeted antibodies and CAR‑T cell immunotherapies for cancer treatment | — |
| 35 | MOWOOT Developer of a medical device for the treatment of chronic constipation | $4M | 25 mo ago | Series A | 6 | 2014 | WordPressMySQLPHP+21 | — | — |
| 36 | Made of Genes Genomics platform for acquiring, storing, and sharing personal genomic information | $3M | 27 mo ago | Seed | 20 | 2015 | WordPressMySQLPHP+25 | — | — |
| 37 | Gate2Brain Developer of platform for the delivery of therapeutics across biological barriers | $3M | 34 mo ago | Funding Raised | 10 | 2019 | — | 14 patents Peptide-based water‑soluble delivery platforms for anticancer drugs and BBB‑crossing antibody therapeutics | 1 partnership |
| 38 | Aptadel Therapeutics Developer of RNA-based therapeutics to treat cancer | $3M | 2 mo ago | Seed | 7 | 2020 | — | 3 patents Aptamer therapeutics targeting EPHA2 receptor for cancer treatment | 1 launch |
| 39 | GlyCardial Diagnostics In vitro diagnostic for myocardial ischemia | $3M | 53 mo ago | Series A | 7 | 2017 | — | 14 patents Glycosylated ApoJ‑specific antibodies for diagnostic biomarkers and ischemia therapy | — |
| 40 | Methinks Provider of AI and cloud-based software for the diagnosis of strokes | $3M | 2 mo ago | Seed | 17 | 2016 | WebflowApple iCloud MailMicrosoft 365+12 | — | 1 job opening |
| 41 | Affirma Biotech Developer of drugs against multi-drug resistant bacteria | $2M | 28 mo ago | Seed | 3 | 2020 | — | 6 patents PD‑L1 immune checkpoint inhibitor small‑molecule therapeutics | — |
| 42 | Flomics Provider of liquid biopsy-based diagnostics services | $2M | 27 mo ago | Seed | 19 | 2018 | WordPressPleskMySQL+19 | — | — |
| 43 | Innerva Pharmaceuticals Developer of drugs for the treatment of ocular pain | $2M | 43 mo ago | Seed | — | 2021 | — | — | — |
| 44 | ELEM Biotech Provider of a simulation based platform for doctors | $2M | 36 mo ago | Seed | 24 | 2018 | YouTubeBootstrapAmazon Web Services+9 | 14 patents Computational biomechanics for muscle electrophysiology, fiber estimation, and ventricle assist device optimization | — |
| 45 | Superlativa Provider of supplements for stress relief, hormonal balance, and digestive health | $2M | 18 mo ago | Seed | — | 2020 | Cart FunctionalityShopifySentry+45 | — | 1 award |
| 46 | ZYMVOL Provider of enzyme engineering services using computational and AI-driven molecular modeling | $1M | 15 mo ago | Seed | 28 | 2017 | WordPressMySQLPHP+21 | — | 1 launch |
| 47 | DOMMA Developer of supplements and functional foods for women health | $1M | 28 mo ago | Seed | 7 | 2021 | Cart FunctionalityShopifyTailwind CSS+34 | — | — |
| 48 | Nanobots Therapeutics Developer of therapeutics for the treatment of cancer | $509K | 18 mo ago | Seed | 6 | 2023 | Froala EditorVimeoBootstrap+14 | — | 1 award |
| 49 | Dipneo Developer of automatic resuscitation device for out-of-hospital cardiac arrests | $323K | 23 mo ago | Seed | — | 2023 | — | — | — |
| 50 | Robopedics Developer of robotic orthopedic solution for people with walking disabilities | $291K | 12 mo ago | Seed | — | 2021 | Webflowlit-htmllit-element+12 | — | — |
Top 12 Life Sciences companies in Barcelona
#1
Series A · Barcelona, Catalonia · founded 2024$61.5Mraised▾
Series A · Barcelona, Catalonia · founded 2024
Provider of a clinical assistant platform for drug development. It uses AI technology to de-risk and accelerate clinical trials, streamlining the process for pharmaceutical companies
LinkedIn Pulse recent public activity · Jul 2026
Audience: 13k LinkedIn followers — 4.8% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
- Feb 2026Series A$52M
- Jul 2025Seed$5.8M
- Nov 2024Seed$3.7M
Founders & team
Investors
YZR Capital, MSM, Plug and Play Tech Center, Pathena Family Office, Outsized Ventures, Norrsken VC
Tech stack
ActivecampaignApple Icloud MailCloudflareCloudflare Bot ManagementFramer SitesGoogle Analytics
#2
Series C · Barcelona, Catalonia · founded 2014 · 18 employees$22.6Mraised▾
Series C · Barcelona, Catalonia · founded 2014 · 18 employees
Peptomyc, a spin-off of the Vall d’Hebron Institute of Oncology (VHIO) is focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. Its lead peptide Omomyc-CPP is in the preclinical stage.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Funding rounds
- Apr 2026Series C$5.8M
- Feb 2026Series B—
- Oct 2023Grant (prize money)$2.6M
- Oct 2023Series B$2.6M
Founders & team
Investors
EIC Fund, Europa, Alta Life Sciences, Healthequity, Vall d'Hebron Barcelona Hospital, Aurora Science
Tech stack
Apache Http ServerBootstrapEngintronGoogle AnalyticsGoogle PagespeedGsap
#3
Series A · Barcelona, Catalonia · founded 2015 · 24 employees$9.5Mraised▾
Series A · Barcelona, Catalonia · founded 2015 · 24 employees
Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 partnerships (incl. XtalPi Inc.) announced in 12 mo
Funding rounds
- Feb 2026Series A$7.1M
- Aug 2022Grant (prize money)$50.1K
- Sep 2020Grant (prize money)$1.1M
- Apr 2020Grant (prize money)$1.1M
Founders & team
Investors
Europa, EIC Fund, HERAN Partners, Clave, Inveready, Bio&Tech Smart Capital
Tech stack
WordpressMysqlPhpTwenty Twenty-TwoBootstrapElementor
#4
Series A · Barcelona, Catalonia · founded 2019 · 25 employees$35.5Mraised▾
Series A · Barcelona, Catalonia · founded 2019 · 25 employees
Ona Therapeutics provides therapeutics solution for metastatic cancer. It is a spin-off of ICREA and IRB and involved in developing biologics targeting the metastatic-initiating cells and lipid metabolism for the treatment of cancer.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
- Oct 2025Series A$11.6M
- Dec 2020Grant (prize money)—
- Jun 2020Series A$33.8M
- May 2019Seed$1.7M
Founders & team
Investors
Asabys Partners, Alta Life Sciences, Bpifrance, Ysios Capital, Fund+, Eureka
Tech stack
AkismetBluehostBugherdContact Form 7Creativ.EmailEndurance Page Cache
#5
Series B · Barcelona, Catalonia · founded 2019 · 52 employees$82.8Mraised▾
Series B · Barcelona, Catalonia · founded 2019 · 52 employees
Developer of implantable neurotechnology for decoding and modulating brain activity. The company focuses on creating bi-directional, high-resolution brain-computer interfaces. These interfaces enable real-time smart neural decoding and modulation in closed loop. The company's platform combines hardware and data analytics to personalize therapy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 27k LinkedIn followers — 10.3% of this cohort's audience
Activity: 1 partnerships (incl. IMPHORIA) announced in 12 mo
Funding rounds
- May 2025Grant (prize money)$4.5M
- Oct 2024Series B$50M
- Dec 2023Venture Debt$22.1M
- Oct 2023Series A—
Founders & team
Investors
CDTI, Gencat, imec.xpand, Axis, EIC Fund, Asabys Partners
Tech stack
BootstrapContact Form 7GsapHttp/3JqueryJquery Migrate
#6
Series A · Barcelona, Catalonia · founded 2013 · 10 employees$7Mraised▾
Series A · Barcelona, Catalonia · founded 2013 · 10 employees
Developer of a first-in-class oral drug improving embryo implantation. It offers a drug, OXO-001, to increase embryo implantation success and pregnancy rates. It addresses implantation failure or early pregnancy loss, major causes of failure in female fertility treatments. The company is also studying the use of OXO-001 to treat infertility associated with Polycystic ovary syndrome (PCOS).
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Feb 2026Grant (prize money)$3M
- Dec 2022Grant (prize money)$2.5M
- 2020Seed$1.4M
- Jun 2020Series A$5.7M
Founders & team
Investors
EIT Health, Ciencia, Inveready, CDTI, Bstartup Banco Sabadell, European Innovation Council
Tech stack
WordpressMysqlPhpGenesis ThemeBootstrapContact Form 7
#7
Series B · Barcelona, Catalonia · founded 2020 · 24 employees$56.7Mraised▾
Series B · Barcelona, Catalonia · founded 2020 · 24 employees
Provider of a proprietary platform for gene therapy. The company offers proprietary intein platform technology for treating patients suffering from rare genetic diseases. The company's lead program is in Stargardt disease, the most common inherited retinal disorder caused by mutations in a single gene ABCA4.
Fliar Intelligence Index™ 37how this company ranks against its industry peers
Funding
top 29%Growth
top 45%Moat
top 48%Tech
bottom 49%Talent
bottom 49%Global
bottom 38%Funding: Raised $56.7M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) · Last round Series B (Jun 2025)
Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 5/10 · 10 curated direct competitors tracked
Audience (LinkedIn): 11k LinkedIn followers — 4.2% of this cohort's audience
Funding rounds
- Jun 2025Series B$135M
- Feb 2022Series A$56.7M
- Sep 2020Seed—
Founders & team
Investors
Ysios Capital, Asabys Partners, Caixa Capital Risc, UCB Ventures, New Enterprise Associates, Gilde Healthcare
Tech stack
Anime.JsCloudflareCloudflare Bot ManagementCloudflare Browser InsightsContact Form 7Cookieyes
#8
Seed · Barcelona, Catalonia · founded 2016 · 17 employees$2.7Mraised▾
Seed · Barcelona, Catalonia · founded 2016 · 17 employees
Methinks provides AI and cloud-based software for the diagnosis of strokes. It allows the radiologist to assess stroke treatment from a non-contrast CT. It also provides a communication feature that allows coordination among hospitals, stroke units, and healthcare professionals.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 2.7% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Customer Success Specialist
Funding rounds
- Nov 2023Seed—
- Feb 2023Grant (prize money)$2.7M
- Dec 2020Grant (prize money)—
Founders & team
Investors
Europa, EIC Fund, EIT Health, Aei, Nina Capital, Moebio
#9
Seed · Barcelona, Catalonia · founded 2020 · 7 employees$2.8Mraised▾
Seed · Barcelona, Catalonia · founded 2020 · 7 employees
Developer of RNA-based therapeutics to treat cancer. The company's technology is based on RNA-Aptamers to deliver different therapeutic agents to treat a wide variety of cancers. The company's lead candidate drug is ADEL-101 for Ewing Sarcoma, a rare variety of bone cancer in children and young adults.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: HEAD of R&D
Activity: 1 product launches announced in 12 mo
Funding rounds
- Mar 2026Seed$2.3M
- 2025Seed$498.5K
Founders & team
Investors
Newsight Tech Angels, Littlewarrior
#10
Early Stage · Barcelona, Catalonia · founded 2020 · 5 employees$4.4Mraised▾
Early Stage · Barcelona, Catalonia · founded 2020 · 5 employees
Developer of cell therapies for the treatment of hematological malignancies. The company is developing CAR T cell products against a novel target overexpressed in several hematological malignancies. The product line inlcudes ARI-0001 and ARI-0002 for chronic lymphocytic leukemia (CLL), Burkitt’s lymphoma, acute myeloid leukemia (AML), or T-cell acute lymphoblastic leukemia (T-ALL).
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
- Feb 2026Grant (prize money)$4.4M
Investors
Ciencia, Invivo Partners, Nara Capital, CDTI
#11
Series A · Barcelona, Catalonia · founded 2018 · 19 employees$21.1Mraised▾
Series A · Barcelona, Catalonia · founded 2018 · 19 employees
AORTYX is a developer of smart devices for aortic diseases. It has developed endovascular devices to treat vascular diseases. It uses tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta. The device is bioresorbable, viscoelastic, thrombogenic, and can be used as a local drug delivery platform.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Jun 2025Series A$15.8M
- May 2022Grant (prize money)$2.6M
- Dec 2021Grant (prize money)$2.5M
- Feb 2020Grant (prize money)$55K
Founders & team
Investors
EIT Health, Europa, EIC Fund, Ship2B Ventures, Clave, Nara Capital
#12
Public · Barcelona, Catalonia · founded 2000 · 43 employees$24.9Mraised▾
Public · Barcelona, Catalonia · founded 2000 · 43 employees
Developer of treatments solutions for cancer and neurodegenerative diseases using epigenetic technology platforms. It uses a proprietary epigenetic platform to identify drug targets for cancer and neurodegenerative diseases. Its lead candidate targets lysine-specific demethylase - 1 (LSD-1) for Alzheimer's, Parkinson's, Huntington's, and certain other rare diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
- Apr 2025Post IPO$34.1M
- Sep 2021Grant (prize money)$1M
- Jul 2019Post IPO$22.3M
- Mar 2017Post IPO$19.5M
Founders & team
Investors
Kabukisyndromefoundation, Inveready, Najeti, Catalonia Trade & Investment
Tech stack
Apple Icloud MailBootstrapCloudflareDrupalGoogle AnalyticsGoogle Font Api
Funding & investor landscape
$819.1Mtotal disclosed funding
86companies funded
229disclosed rounds
2rounds last 90 days
Most active investors
Notable founders
Diogo Pisoeiro
Co-Founder & Chief Product Officer · Biorce
Pedro Coelho
Co-Founder & CEO · Biorce
Marie-Eve Beaulieu
Co-Founder · Peptomyc
Laura Soucek
Co-Founder & Chief Scientific Officer · Peptomyc
Enric Codina
Co-Founder & CEO · Pharmacelera
Enric Herrero
Co-Founder & CTO · Pharmacelera
Valerie Vanhooren
Co-Founder & CEO · Ona Therapeutics
Salvador Benitah
Co-Founder · Ona Therapeutics
Kostas Kostarelos
Co-Founder · INBRAIN Neuroelectronics
Mario Capizzani
Co-Founder & CCO · INBRAIN Neuroelectronics
Ignasi Almazan
Co-Founder · Oxolife
Agnes Arbat
Chief Executive Officer and Chief Marketing Officer · Oxolife
Prism market signals · Spain · country-scoped Prism corpus, 1,393,736 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN BARCELONA · Health & Bio
How research on Biotechnology in Barcelona is moving
A read on the academic research around Biotechnology in Barcelona — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 67 papers.
Barcelona's Universitat Autònoma de Barcelona, Universitat de Barcelona, and Hospital Clínic de Barcelona lead predominantly recent research on extracellular vesicles and antibiotic resistance, with a cautiously optimistic tone.
67 papers · stance +0.39 · 35% breakthrough · 21% concern
top institutions
- Universitat Autònoma de Barcelona25
- Universitat de Barcelona23
- Hospital Clínic de Barcelona7
- Barcelona Institute for Global Health5
- Instituto de Investigaciones Químicas y Ambientales de Barcelona3
leading researchers
Eric Voltà-Durán · Raquel Barrena · Adriana Artola · Antoni Sánchez · Beatriz G. de la Torre · Bolen, MacKenzie L.
prism intelligence · tone & topics
90% positive · 4% critical tone
PharmaceuticalsHealthMedical ResearchAgricultureHealthcareClinical Trials
▲
Breakthroughs18 · 27%
▲ 0%→30% share
0 median citations94% since 2021mostly methods-led
Mycotoxin and detection-limit research newly captures 30% of breakthrough papers, signalling rapid analytical focus.
rising sub-themes (early→recent)
- Context (archaeology)2
- Mycotoxin2
- Detection limit2
- Aflatoxin1
- Irrigation1
Landmark ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1 · 495 cites
◆
Advancements23 · 34%
▲ 0%→34% share
0 median citations87% since 2021mostly empirical
Replication-statistics and fermentation topics are newly emerging, together driving 34% of advancement papers across 67 studies.
rising sub-themes (early→recent)
- Replication (statistics)4
- Fermentation3
- Thermophile2
- Raw material2
- Bioprocess2
Newly emergingReplication (statistics) 0→4 · Fermentation 0→3
Landmark Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections · 920 cites
▼
Concerns11 · 16%
▼ 100%→12% share
▼0.1× share momentum0 median citations73% since 2021mostly reviews
Antimicrobial research tripled (1→3 papers) though concerns segment shrank from 100% to 12% field-share.
rising sub-themes (early→recent)
- Antimicrobial1→3
Landmark Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper · 1,450 cites
Common questions
How many Life Sciences companies are there in Barcelona, Spain?
Radar tracks 178 indexable Life Sciences companies headquartered in Barcelona, Spain that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Barcelona, Spain?
The Life Sciences companies in Barcelona, Spain on this list have raised a combined $819.1M in disclosed equity funding across 86 funded companies.
Which is the highest-funded Life Sciences company in Barcelona, Spain?
INBRAIN Neuroelectronics is the highest-funded Life Sciences company in Barcelona, Spain, with $82.8M in disclosed equity funding.
How many Life Sciences companies in Barcelona, Spain are funded?
86 of the 178 Life Sciences companies in Barcelona, Spain on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Barcelona, Spain?
None of the Life Sciences companies in Barcelona, Spain on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Barcelona, Spain Life Sciences companies?
The most active investors in Barcelona, Spain Life Sciences companies on this list include Europa, EIC Fund, Caixa Capital Risc, EIT Health, Inveready.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.